About

Bristol Myers Squibb on globaali biolääkeyritys, joka on sitoutunut kehittämään innovatiivisia lääkkeitä vaikeiden sairauksien hoitoon. Lääkkeemme auttavat miljoonia ihmisiä ympäri maailmaa heidän taistelussa mm. syöpää, sydän- ja verisuonitauteja, sekä immunologisia sairauksia vastaan.

Address

Oy Bristol-Myers Squibb (Finland) Ab
Tammasaarenkatu 3,
00180 Helsinki

Contact details

Medical Information phone number
+358 9 2512 1244

Medical Information website
Bristol Myers Squibb Medical Information Online for Finland

Medical Information email
medinfo.finland@bms.com

Adverse events and product complaints

To report an Adverse Event please contact us at:

Adverse event phone number
+358 9 2512 1244

Adverse event email
medinfo.finland@bms.com

Website
https://www.bms.com/fi

BMS products

Medicinal products marked withare subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z

Abraxane®
(nab-paclitaxel)

Azactam®
(aztreonam)

Baraclude®
(entecavir)

Camzyos®
(mavacamten)

Eliquis® (Co-Promoted Pfizer)
(apixaban)

Empliciti®
(elotuzumab)

Imnovid®
( pomalidomide)

Onureg®
(azacitidine tablets)

Opdivo®
(nivolumab)

Opdualag®
(nivolumab + relatlimab)

Orencia®
(abatacept)

Reblozyl®
(luspatercept)

Revlimid®
(lenalidomide)

Sotyktu®
(deucravacitinib)

Sprycel®
(dasatinib)

Thalidomide BMS®
(thalidomide)

Vidaza®
(azacitidine)

Yervoy®
(ipilimumab)

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z
Page last updated: 12/04/2024